{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:36:34Z","timestamp":1790674594129,"version":"4.1.0"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T00:00:00Z","timestamp":1378339200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0073664","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T21:02:41Z","timestamp":1378414961000},"page":"e73664","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":59,"title":["Regulation of Hippocampal cGMP Levels as a Candidate to Treat Cognitive Deficits in Huntington\u2019s Disease"],"prefix":"10.1371","volume":"8","author":[{"given":"Ana","family":"Saavedra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Arum\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Alberch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"P\u00e9rez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,9,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JHD-120023","article-title":"Cognitive dysfunction in Huntington\u2019s disease: humans, mouse models and molecular mechanisms","volume":"1","author":"A Giralt","year":"2012","journal-title":"J Huntington\u2019s Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1093\/hmg\/ddr351","article-title":"Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington\u2019s disease","volume":"20","author":"A Giralt","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/978-3-540-68964-5_24","article-title":"cGMP signalling in the mammalian brain: role in synaptic plasticity and behaviour","author":"T Kleppisch","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-540-68964-5_1","article-title":"A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases","author":"AY Kots","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-3-540-68964-5_7","article-title":"Cyclic nucleotide-gated channels","author":"M Biel","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"AT Bender","year":"2006","journal-title":"Pharmacol Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-3-540-68964-5_8","article-title":"cGMP regulated protein kinases (cGK)","author":"F Hofmann","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12035-010-8104-x","article-title":"Cyclic GMP and nitric oxide synthase in aging and Alzheimer\u2019s disease","volume":"41","author":"KU Domek-\u0141opaci\u0144ska","year":"2010","journal-title":"Mol Neurobiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0306-4522(95)00596-X","article-title":"Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington\u2019s disease","volume":"72","author":"PJ Norris","year":"1996","journal-title":"Neuroscience"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-8993(01)03000-1","article-title":"Reduced activity and protein expression of NOS in R6\/2 HD transgenic mice: effects of L-NAME on symptom progression","volume":"919","author":"AW Deckel","year":"2001","journal-title":"Brain Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0006-8993(02)02550-7","article-title":"Altered neuronal nitric oxide synthase expression contributes to disease progression in Huntington\u2019s disease transgenic mice","volume":"939","author":"AW Deckel","year":"2002","journal-title":"Brain Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/00001756-200204160-00034","article-title":"Biphasic developmental changes in Ca2+\/calmodulin-dependent proteins in R6\/2 Huntington\u2019s disease mice","volume":"13","author":"AW Deckel","year":"2002","journal-title":"Neuroreport"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0006-8993(02)03102-5","article-title":"Age-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntington\u2019s disease mutation","volume":"951","author":"F P\u00e9rez-Severiano","year":"2002","journal-title":"Brain Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/brain\/awh058","article-title":"Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington\u2019s mouse model","volume":"127","author":"BR Jarabek","year":"2004","journal-title":"Brain"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.2174\/138161206777698855","article-title":"Improving memory: a role for phosphodiesterases","volume":"12","author":"A Blokland","year":"2006","journal-title":"Curr Pharm Des"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2147\/NDT.S2447","article-title":"Role of phosphodiesterase 5 in synaptic plasticity and memory","volume":"4","author":"D Puzzo","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00213-008-1273-x","article-title":"Selective phosphodiesterase inhibitors: a promising target for cognition enhancement","volume":"202","author":"OA Reneerkens","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.2174\/138161205774370799","article-title":"Phosphodiesterase inhibitors for cognitive enhancement","volume":"11","author":"GM Rose","year":"2005","journal-title":"Curr Pharm Des"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2165\/0023210-200822120-00002","article-title":"The role of phosphodiesterases in schizophrenia : therapeutic implications","volume":"22","author":"JA Siuciak","year":"2008","journal-title":"CNS Drugs"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/978-3-642-17969-3_19","article-title":"Phosphodiesterases in the central nervous system: implications in mood and cognitive disorders","author":"Y Xu","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"ref22","first-page":"47","article-title":"Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction","volume":"8","author":"M Boolell","year":"1996","journal-title":"Int J Impot Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.neurobiolaging.2011.03.018","article-title":"Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model","volume":"33","author":"L Orejana","year":"2012","journal-title":"Neurobiol Aging"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2012.10.060","article-title":"Inhibition of phosphodiesterase-5 rescues age-related impairment of synaptic plasticity and memory","volume":"240","author":"A Palmeri","year":"2013","journal-title":"Behav Brain Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/j.1476-5381.2011.01517.x","article-title":"Sildenafil restores cognitive function without affecting beta-amyloid burden in a mouse model of Alzheimer\u2019s disease","volume":"164","author":"M Cuadrado-Tejedor","year":"2011","journal-title":"Br J Pharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1523\/JNEUROSCI.0864-09.2009","article-title":"Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer\u2019s disease mouse model","volume":"29","author":"D Puzzo","year":"2009","journal-title":"J Neurosci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbr.2013.05.017","article-title":"Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP\/PS1 transgenic mice","volume":"250","author":"J Zhang","year":"2013","journal-title":"Behav Brain Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.neuroscience.2010.08.065","article-title":"Treatment with sildenafil prevents impairment of learning in rats born to pre-eclamptic mothers","volume":"171","author":"O Cauli","year":"2010","journal-title":"Neuroscience"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/hep.20565","article-title":"Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts","volume":"41","author":"S Erceg","year":"2005","journal-title":"Hepatology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.neuroscience.2008.11.024","article-title":"Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression","volume":"158","author":"A Giralt","year":"2009","journal-title":"Neuroscience"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.nbd.2012.12.008","article-title":"Brain region- and age-dependent dysregulation of p62 and NBR1 in a mouse model of Huntington\u2019s disease","volume":"52","author":"L Ru\u00e9","year":"2013","journal-title":"Neurobiol Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","article-title":"Length-dependent gametic CAG repeat instability in the Huntington\u2019s disease knock-in mouse","volume":"8","author":"VC Wheeler","year":"1999","journal-title":"Hum Mol Genet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"L Mangiarini","year":"1996","journal-title":"Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1523\/JNEUROSCI.3446-10.2011","article-title":"Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington\u2019s disease: a STEP in the resistance to excitotoxicity","volume":"31","author":"A Saavedra","year":"2011","journal-title":"J Neurosci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/00008877-199912000-00004","article-title":"Effects of sildenafil on long-term retention of an inhibitory avoidance response in mice","volume":"10","author":"CM Baratti","year":"1999","journal-title":"Behav Pharmacol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.pbb.2004.09.019","article-title":"Phosphodiesterase inhibition by sildenafil citrate attenuates the learning impairment induced by blockade of cholinergic muscarinic receptors in rats","volume":"79","author":"BD Devan","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.pbb.2012.01.017","article-title":"Effects of protein kinase A and G inhibitors on hippocampal cholinergic markers expressions in rolipram- and sildenafil-induced spatial memory improvement","volume":"101","author":"A Hosseini-Sharifabad","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0306-4522(02)00199-9","article-title":"Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat","volume":"113","author":"J Prickaerts","year":"2002","journal-title":"Neuroscience"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00213-004-1967-7","article-title":"Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation","volume":"177","author":"J Prickaerts","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.neubiorev.2007.01.005","article-title":"The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents","volume":"31","author":"E Dere","year":"2007","journal-title":"Neurosci Biobehav Rev"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(96)00427-1","article-title":"Role of dorsal hippocampus in acquisition, consolidation and retrieval of rat\u2019s passive avoidance response: a tetrodotoxin functional inactivation study","volume":"730","author":"CG Ambrogi Lorenzini","year":"1996","journal-title":"Brain Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0006-8993(97)00651-3","article-title":"Role of ventral hippocampus in acquisition, consolidation and retrieval of rat\u2019s passive avoidance response memory trace","volume":"768","author":"CG Ambrogi Lorenzini","year":"1997","journal-title":"Brain Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuropharm.2010.05.004","article-title":"Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues","volume":"59","author":"V Lakics","year":"2010","journal-title":"Neuropharmacology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/cne.10955","article-title":"mRNA expression patterns of the cGMP-hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain","volume":"467","author":"WC van Staveren","year":"2003","journal-title":"J Comp Neurol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/hmg\/ddr552","article-title":"Long-term memory deficits in Huntington\u2019s disease are associated with reduced CBP histone acetylase activity","volume":"21","author":"A Giralt","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.nbd.2007.11.006","article-title":"Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington\u2019s disease transgenic mice","volume":"29","author":"J Nithianantharajah","year":"2008","journal-title":"Neurobiol Dis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e28409","DOI":"10.1371\/journal.pone.0028409","article-title":"Onset and progression of behavioral and molecular phenotypes in a novel congenic R6\/2 line exhibiting intergenerational CAG repeat stability","volume":"6","author":"RM Cowin","year":"2011","journal-title":"PLOS ONE"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-2999(01)01614-4","article-title":"cGMP, but not cAMP, in rat hippocampus is involved in early stages of object memory consolidation","volume":"436","author":"J Prickaerts","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00001756-199601310-00050","article-title":"Hippocampal cGMP and cAMP are differentially involved in memory processing of inhibitory avoidance learning","volume":"7","author":"R Bernabeu","year":"1996","journal-title":"Neuroreport"},{"key":"ref50","first-page":"672","article-title":"Beta-adrenergic receptors link NO\/sGC\/PKG signaling to BDNF expression during the consolidation of object recognition long-term memory","volume":"20","author":"CR Furini","year":"2010","journal-title":"Hippocampus"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/00001756-199507310-00008","article-title":"Role of hippocampal NO in the acquisition and consolidation of inhibitory avoidance learning","volume":"6","author":"R Bernabeu","year":"1995","journal-title":"Neuroreport"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1097\/00001756-199707070-00026","article-title":"Further evidence for the involvement of a hippocampal cGMP\/cGMP-dependent protein kinase cascade in memory consolidation","volume":"8","author":"R Bernabeu","year":"1997","journal-title":"Neuroreport"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000080104","article-title":"Modulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy","volume":"72","author":"CS Patil","year":"2004","journal-title":"Pharmacology"},{"key":"ref54","first-page":"373","article-title":"Modulatory effect of sildenafil in diabetes and electroconvulsive shock-induced cognitive dysfunction in rats","volume":"58","author":"CS Patil","year":"2006","journal-title":"Pharmacol Rep"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1002\/jnr.21788","article-title":"In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats","volume":"86","author":"A Marte","year":"2008","journal-title":"J Neurosci Res"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1471-4159.2008.05825.x","article-title":"Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat","volume":"108","author":"E Puerta","year":"2009","journal-title":"J Neurochem"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1161\/01.STR.0000034399.95249.59","article-title":"Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats","volume":"33","author":"R Zhang","year":"2002","journal-title":"Stroke"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainres.2008.02.108","article-title":"The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging","volume":"1216","author":"K Domek-\u0141opaci\u0144ska","year":"2008","journal-title":"Brain Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/ijir.2011.13","article-title":"Effects of repeated dosing with Udenafil (Zydena) on cognition, somatization and erection in patients with erectile dysfunction: a pilot study","volume":"23","author":"YS Shim","year":"2011","journal-title":"Int J Impot Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0073664","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T07:52:11Z","timestamp":1596441131000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0073664"}},"subtitle":[],"editor":[{"given":"Pedro","family":"Gonzalez-Alegre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,9,5]]},"references-count":59,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0073664","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,5]]}}}